Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Tofacitinib on Coagulation and Platelet Function in Ulcerative Colitis
NCT05313620Phase 4Completed
- Sponsor
- Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
- Start
- Apr 2022
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tofacitinib oral solution in ulcerative colitis (UC), sponsored by Fundación de Investigación Biomédica del Hospital Universitario de La Princesa. Started Apr 2022; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05313620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05313620.